Izraeli S - Search Results

1

Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infection.

Izraeli S, Mueller BU, Ling A, Temeck BK, Lewis LL, Chang R, Shad AT, Pass HI, Pizzo PA. Izraeli S, et al. Pediatr Infect Dis J. 1996 Feb;15(2):112-6. doi: 10.1097/00006454-199602000-00005. Pediatr Infect Dis J. 1996. PMID: 8822282

2

Acute pancreatitis after ifosfamide therapy.

Izraeli S, Adamson PC, Blaney SM, Balis FM. Izraeli S, et al. Cancer. 1994 Sep 1;74(5):1627-8. doi: 10.1002/1097-0142(19940901)74:5<1627::aid-cncr2820740522>3.0.co;2-u. Cancer. 1994. PMID: 8062195

3

A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.

Ho PT, Zimmerman K, Wexler LH, Blaney S, Jarosinski P, Weaver-McClure L, Izraeli S, Balis FM. Ho PT, et al. Among authors: izraeli s. Cancer. 1995 Dec 15;76(12):2557-64. doi: 10.1002/1097-0142(19951215)76:12<2557::aid-cncr2820761223>3.0.co;2-9. Cancer. 1995. PMID: 8625085

4

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M. Lebanony D, et al. Among authors: izraeli s. J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273703

5

Integration of a palliative and terminal care center into a comprehensive pediatric oncology department.

Golan H, Bielorai B, Grebler D, Izraeli S, Rechavi G, Toren A. Golan H, et al. Among authors: izraeli s. Pediatr Blood Cancer. 2008 May;50(5):949-55. doi: 10.1002/pbc.21476. Pediatr Blood Cancer. 2008. PMID: 18240176

6

Branhamella catarrhalis as a cause of suppurative arthritis.

Izraeli S, Flasterstein B, Shamir R, Rachmel A, Nitzan M, Drucker M, Samra Z. Izraeli S, et al. Pediatr Infect Dis J. 1989 Apr;8(4):256-7. Pediatr Infect Dis J. 1989. PMID: 2497437 No abstract available.

7

Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma.

Bielorai B, Meyer C, Trakhtenbrot L, Golan H, Rozner E, Amariglio N, Izraeli S, Marschalek R, Toren A. Bielorai B, et al. Among authors: izraeli s. Cancer Genet Cytogenet. 2010 Dec;203(2):288-91. doi: 10.1016/j.cancergencyto.2010.08.002. Cancer Genet Cytogenet. 2010. PMID: 21156246

8

Expression of the SIL gene is correlated with growth induction and cellular proliferation.

Izraeli S, Colaizzo-Anas T, Bertness VL, Mani K, Aplan PD, Kirsch IR. Izraeli S, et al. Cell Growth Differ. 1997 Nov;8(11):1171-9. Cell Growth Differ. 1997. PMID: 9372240

9

Molecular medicine--an overview.

Izraeli S, Rechavi G. Izraeli S, et al. Isr Med Assoc J. 2002 Aug;4(8):638-40. Isr Med Assoc J. 2002. PMID: 12183874 Free article. Review.

10

Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer.

Einav U, Tabach Y, Getz G, Yitzhaky A, Ozbek U, Amariglio N, Izraeli S, Rechavi G, Domany E. Einav U, et al. Among authors: izraeli s. Oncogene. 2005 Sep 22;24(42):6367-75. doi: 10.1038/sj.onc.1208797. Oncogene. 2005. PMID: 16007187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters